Views & Analysis Digital health round-up: Apple's 'one-stop shop' Can Apple succeed where others can't?
Views & Analysis Verily, Novartis join fund to support Europe’s biotech entre... New $300m fund aimed at helping European biotechs to grow, providing alternative to an IPO or 'generally suboptimal' licensing or big pharma acquisition
Views & Analysis Digital health round-up: Apple ventures into the Land of Nod Apple becomes first 'big tech' firm to investigate sleep technology.
News Verily launches ambitious Project Baseline Study will create a comprehensive database reference for researchers.
News Verily unveils the Study Watch, a clinical trials-only weara... Device will be used in several upcoming clinical studies.
Views & Analysis Why Novartis and Verily should abandon their smart lens idea Technical officer hinted that the firm has hit obstacles to its ambitious projects.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
